miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

BACKGROUND: Gemcitabine-based chemotherapy is the standard treatment for pancreatic cancer. However, the issue of resistance remains unresolved. The aim of this study was to identify microRNAs (miRNAs) that govern the resistance to gemcitabine in pancreatic cancer. METHODS: miRNA microarray analysis...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwagami, Y, Eguchi, H, Nagano, H, Akita, H, Hama, N, Wada, H, Kawamoto, K, Kobayashi, S, Tomokuni, A, Tomimaru, Y, Mori, M, Doki, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Genetics and Genomics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721395/
https://www.ncbi.nlm.nih.gov/pubmed/23799850
http://dx.doi.org/10.1038/bjc.2013.320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721395/
https://www.ncbi.nlm.nih.gov/pubmed/23799850
http://dx.doi.org/10.1038/bjc.2013.320

Ejemplares similares